The Regenstrief Institute and Merck signed a five-year agreement to collaborate on projects that will use clinical data to inform personalized delivery of healthcare, according to the release. The organizations will explore new ways to study diseases and interventions for chronic conditions such as diabetes, cardiovascular disease and osteoporosis.
The overall goal is to improve the health of patients through data analytics, healthcare innovation, education and research that supports evidence-based healthcare, according to the report.
More Articles on Healthcare Strategy:
UCSF Medical Center CEO Calls for New Approach in Academic Medical Centers
7-Part Strategy to Increase the Value of Healthcare
Mission Health’s McDowell Hospital to Develop Long-Range Strategic Plan
